Cargando…

Reproducible research practices, transparency, and open access data in the biomedical literature, 2015–2017

Currently, there is a growing interest in ensuring the transparency and reproducibility of the published scientific literature. According to a previous evaluation of 441 biomedical journals articles published in 2000–2014, the biomedical literature largely lacked transparency in important dimensions...

Descripción completa

Detalles Bibliográficos
Autores principales: Wallach, Joshua D., Boyack, Kevin W., Ioannidis, John P. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245499/
https://www.ncbi.nlm.nih.gov/pubmed/30457984
http://dx.doi.org/10.1371/journal.pbio.2006930
_version_ 1783372254904582144
author Wallach, Joshua D.
Boyack, Kevin W.
Ioannidis, John P. A.
author_facet Wallach, Joshua D.
Boyack, Kevin W.
Ioannidis, John P. A.
author_sort Wallach, Joshua D.
collection PubMed
description Currently, there is a growing interest in ensuring the transparency and reproducibility of the published scientific literature. According to a previous evaluation of 441 biomedical journals articles published in 2000–2014, the biomedical literature largely lacked transparency in important dimensions. Here, we surveyed a random sample of 149 biomedical articles published between 2015 and 2017 and determined the proportion reporting sources of public and/or private funding and conflicts of interests, sharing protocols and raw data, and undergoing rigorous independent replication and reproducibility checks. We also investigated what can be learned about reproducibility and transparency indicators from open access data provided on PubMed. The majority of the 149 studies disclosed some information regarding funding (103, 69.1% [95% confidence interval, 61.0% to 76.3%]) or conflicts of interest (97, 65.1% [56.8% to 72.6%]). Among the 104 articles with empirical data in which protocols or data sharing would be pertinent, 19 (18.3% [11.6% to 27.3%]) discussed publicly available data; only one (1.0% [0.1% to 6.0%]) included a link to a full study protocol. Among the 97 articles in which replication in studies with different data would be pertinent, there were five replication efforts (5.2% [1.9% to 12.2%]). Although clinical trial identification numbers and funding details were often provided on PubMed, only two of the articles without a full text article in PubMed Central that discussed publicly available data at the full text level also contained information related to data sharing on PubMed; none had a conflicts of interest statement on PubMed. Our evaluation suggests that although there have been improvements over the last few years in certain key indicators of reproducibility and transparency, opportunities exist to improve reproducible research practices across the biomedical literature and to make features related to reproducibility more readily visible in PubMed.
format Online
Article
Text
id pubmed-6245499
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-62454992018-12-01 Reproducible research practices, transparency, and open access data in the biomedical literature, 2015–2017 Wallach, Joshua D. Boyack, Kevin W. Ioannidis, John P. A. PLoS Biol Meta-Research Article Currently, there is a growing interest in ensuring the transparency and reproducibility of the published scientific literature. According to a previous evaluation of 441 biomedical journals articles published in 2000–2014, the biomedical literature largely lacked transparency in important dimensions. Here, we surveyed a random sample of 149 biomedical articles published between 2015 and 2017 and determined the proportion reporting sources of public and/or private funding and conflicts of interests, sharing protocols and raw data, and undergoing rigorous independent replication and reproducibility checks. We also investigated what can be learned about reproducibility and transparency indicators from open access data provided on PubMed. The majority of the 149 studies disclosed some information regarding funding (103, 69.1% [95% confidence interval, 61.0% to 76.3%]) or conflicts of interest (97, 65.1% [56.8% to 72.6%]). Among the 104 articles with empirical data in which protocols or data sharing would be pertinent, 19 (18.3% [11.6% to 27.3%]) discussed publicly available data; only one (1.0% [0.1% to 6.0%]) included a link to a full study protocol. Among the 97 articles in which replication in studies with different data would be pertinent, there were five replication efforts (5.2% [1.9% to 12.2%]). Although clinical trial identification numbers and funding details were often provided on PubMed, only two of the articles without a full text article in PubMed Central that discussed publicly available data at the full text level also contained information related to data sharing on PubMed; none had a conflicts of interest statement on PubMed. Our evaluation suggests that although there have been improvements over the last few years in certain key indicators of reproducibility and transparency, opportunities exist to improve reproducible research practices across the biomedical literature and to make features related to reproducibility more readily visible in PubMed. Public Library of Science 2018-11-20 /pmc/articles/PMC6245499/ /pubmed/30457984 http://dx.doi.org/10.1371/journal.pbio.2006930 Text en © 2018 Wallach et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Meta-Research Article
Wallach, Joshua D.
Boyack, Kevin W.
Ioannidis, John P. A.
Reproducible research practices, transparency, and open access data in the biomedical literature, 2015–2017
title Reproducible research practices, transparency, and open access data in the biomedical literature, 2015–2017
title_full Reproducible research practices, transparency, and open access data in the biomedical literature, 2015–2017
title_fullStr Reproducible research practices, transparency, and open access data in the biomedical literature, 2015–2017
title_full_unstemmed Reproducible research practices, transparency, and open access data in the biomedical literature, 2015–2017
title_short Reproducible research practices, transparency, and open access data in the biomedical literature, 2015–2017
title_sort reproducible research practices, transparency, and open access data in the biomedical literature, 2015–2017
topic Meta-Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245499/
https://www.ncbi.nlm.nih.gov/pubmed/30457984
http://dx.doi.org/10.1371/journal.pbio.2006930
work_keys_str_mv AT wallachjoshuad reproducibleresearchpracticestransparencyandopenaccessdatainthebiomedicalliterature20152017
AT boyackkevinw reproducibleresearchpracticestransparencyandopenaccessdatainthebiomedicalliterature20152017
AT ioannidisjohnpa reproducibleresearchpracticestransparencyandopenaccessdatainthebiomedicalliterature20152017